相关实验视频
Updated: Jun 29, 2025

06:35
Basics of Multivariate Analysis in Neuroimaging Data
Published on: July 24, 2010
16.9K
基于人工智能的痴呆病因差异诊断基于多式联络数据的多式联络数据
Chonghua Xue1,2, Sahana S Kowshik1,3, Diala Lteif1,4
1Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
medRxiv : the preprint server for health sciences
|April 8, 2024
概括
人工智能模型使用多种数据准确识别痴呆症的原因,改善诊断和个性化护理. 该工具增强了神经病学家的评估,有助于早期发现和管理各种类型的痴呆症.
科学领域:
- 神经学 神经学
- 人工智能的人工智能
- 医学诊断 医学诊断 医学诊断
背景情况:
- 由于症状重叠,对痴呆症的差异诊断具有挑战性,阻碍了个性化管理.
- 准确的病因鉴定对于及时有效的痴呆症护理至关重要.
结论:
- 人工智能框架提供了强大的痴呆症诊断和个性化的管理策略.
- 它显示出作为临床查工具和用于药物试验的潜力.
- 模型预测得到了生物标志物证据和死后发现的验证,证实了其临床实用性.
相关概念视频
Dementia
113
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
113
Alzheimer's Disease: Overview
468
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
468
Alzheimer's Disease: Treatment
183
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
183

